Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
ARMCX2
REST API REST API
Homo sapiens
ARMCX2 is differentially expressed in 249 experiments: 123 organism parts: liver, bone marrow, ... (121 more);, 191 disease states: normal, prostate carcinoma, ... (189 more);, 95 cell types 481 cell lines 18 compound treatments and 58 other conditions.
Synonyms ALEX2, KIAA0512
Orthologs Armcx2 (Mus musculus)   ENSGALG00000008288 (Gallus gallus)   ARMC10 (Danio rerio)   Q1RMT5_BOVIN (Bos taurus)   D4A765_RAT (Rattus norvegicus)   armc10 (Xenopus laevis)   ARMCX2 (Canis familiaris)   (Compare orthologs)
Gene Ontology Term protein binding, membrane, integral to membrane, binding
InterPro Term Armadillo, DUF634
UniProt Accession Q7L311, Q5H9D7, Q5H9D8, Q5H9E1, Q5H9E0
Search EB-eye ENSG00000184867
Show more properties
Experimental Factors
Organism part

studied in E-GEOD-803, E-GEOD-6573, E-GEOD-7540, E-GEOD-3526, E-MTAB-62, ... (26 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-17482, E-GEOD-3860, E-GEOD-5258, E-MEXP-1006, E-GEOD-19639, ... (39 experiments)

Factor Value U/D Experiments
HT1080
2
E-MTAB-37, E-GEOD-20089
KG1
2
E-MTAB-37, E-GEOD-24147
MCF-7
2
E-GEOD-3529, E-GEOD-19639
MDA-MB-231
2
E-TABM-420, E-MTAB-62
MDAMB453
2
E-MTAB-37, E-MTAB-62
MOLT4
2
E-MTAB-62, E-MTAB-37
475 more value(s).


Cell type

studied in E-GEOD-22529, E-GEOD-20193, E-GEOD-3920, E-MEXP-750, E-MEXP-66, ... (44 experiments)

Factor Value U/D Experiments
2
E-TABM-145, E-TABM-130
testis - leydig cell
1
E-AFMX-5
primary CD34- mesenchymal stem cell
1
E-MEXP-66
hMOF over-expressed
1
E-GEOD-20193
mononuclear cell
1
E-GEOD-6053
adipose stem cells derived from adult human donor
1
E-GEOD-20033
89 more value(s).


Disease state

studied in E-GEOD-3307, E-GEOD-2466, E-GEOD-1577, E-MEXP-2280, E-GEOD-16363, ... (51 experiments)

Factor Value U/D Experiments
prostate carcinoma
4
E-GEOD-96, E-MEXP-2034, E-GEOD-3868, E-MTAB-62
colon carcinoma
3
E-MTAB-37, E-MTAB-62, E-GEOD-3726
benign prostatic hyperplasia
2
E-MEXP-2034, E-MEXP-1243
glioblastoma
2
E-GEOD-6014, E-MTAB-37
uterine fibroid
2
E-MTAB-62, E-GEOD-7307
acute lymphoblastic leukemia
1
2
E-MTAB-62, E-MTAB-37, E-GEOD-96
185 more value(s).


Compound treatment

studied in E-GEOD-7400, E-GEOD-4668, E-TABM-782, E-GEOD-15811, E-GEOD-5099, ... (15 experiments)

Factor Value U/D Experiments
granulocyte-colony stimulating factor
1
E-GEOD-7400
5-aza-2'-deoxycytidine + trichostatin A
1
1
E-MEXP-1269
poly(I:C)
1
E-MEXP-1230
17beta-estradiol
3
1
E-GEOD-4668
resveratrol
1
E-TABM-782
Cxcl12
1
E-GEOD-7307
12 more value(s).


BioSourceProvider

studied in E-GEOD-19466, E-GEOD-19519, E-GEOD-19480

Factor Value U/D Experiments
Coriell: GM06993
1
E-GEOD-19519
Coriell: GM14409
1
E-GEOD-19519
Coriell Cell Repositories http://ccr.coriell.org/Sections/Search/Search.aspx?PgId=165&q=GM12891
1
E-GEOD-19466
Coriell: GM14440
1
E-GEOD-19519
Coriell: GM07022
1
E-GEOD-19519
Coriell: GM11830
1
E-GEOD-19519
53 more value(s).


Blood/non-blood meta-groups
studied in E-MTAB-62

Cancer site
studied in E-GEOD-4271

Chromosomal aberration
studied in E-TABM-125

Clinical history
studied in E-TABM-234, E-GEOD-19743, E-GEOD-7967, E-TABM-125, E-GEOD-21374, ... (8 experiments)

Clinical info
studied in E-GEOD-19743, E-MTAB-37, E-GEOD-860, E-MEXP-1251, E-GEOD-2034, ... (11 experiments)

Clinical treatment
studied in E-GEOD-1743, E-GEOD-6532, E-GEOD-21610

coriell cell line repository identifier
studied in E-GEOD-19519

Developmental stage
studied in E-MTAB-62

Disease staging
studied in E-GEOD-19743, E-GEOD-3325, E-GEOD-22148, E-TABM-147, E-GEOD-21138, ... (7 experiments)

Environmental stress
studied in E-GEOD-1643, E-GEOD-1518

Estrogen receptor status
studied in E-GEOD-6532, E-GEOD-20194, E-GEOD-16716

Ethnic group
studied in E-GEOD-1643

Ethnicity
studied in E-GEOD-16363

Genetic modification
studied in E-GEOD-8023, E-MTAB-73, E-GEOD-1823, E-MEXP-1482, E-GEOD-7578, ... (8 experiments)

Genotype
studied in E-TABM-763, E-MEXP-1437, E-GEOD-3494, E-GEOD-2466, E-GEOD-17476, ... (7 experiments)

369 groups
studied in E-MTAB-62

4 groups from blood to incompletely diff
studied in E-MTAB-62

96 groups
studied in E-MTAB-62

Growth condition
studied in E-TABM-263, E-MEXP-1220, E-GEOD-5681, E-GEOD-20540, E-GEOD-20504, ... (12 experiments)

Her2 ihc
studied in E-GEOD-20194, E-GEOD-16716

Histology
studied in E-TABM-234, E-GEOD-16194, E-GEOD-21653, E-TABM-276

Individual
studied in E-TABM-325, E-MTAB-197, E-TABM-740, E-GEOD-2466, E-MEXP-2069, ... (34 experiments)

Infection
studied in E-MEXP-561, E-GEOD-980

Injury
studied in E-GEOD-19743

Karyotype
studied in E-GEOD-7214, E-GEOD-7179

Ki67 ihc
studied in E-GEOD-21653

Light
studied in E-GEOD-1725

Lymph node status
studied in E-GEOD-6532

Material type
studied in E-MEXP-455, E-GEOD-9171

15 meta groups
studied in E-MTAB-62

4 meta groups
studied in E-MTAB-62

6 meta groups
studied in E-MTAB-62

Molecular subtype
studied in E-GEOD-21653

organ
studied in E-GEOD-24283

Organism
studied in E-GEOD-426, E-TABM-84

P53 ihc
studied in E-GEOD-21653

Phenotype
studied in E-GEOD-26495, E-GEOD-1309, E-GEOD-1493, E-GEOD-21750, E-GEOD-1657, ... (7 experiments)

Population
studied in E-GEOD-4922

Progesterone receptor status
studied in E-GEOD-3494, E-GEOD-6532, E-GEOD-20194, E-GEOD-16716

Protocol type
studied in E-GEOD-3254, E-GEOD-21837, E-GEOD-1880, E-GEOD-19246

RNAi
studied in E-GEOD-12438, E-GEOD-3697, E-MEXP-1315, E-MEXP-2759

Sample preparation
studied in E-GEOD-16728

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-19743, E-MEXP-70

sbr grade
studied in E-GEOD-21653

Sex
studied in E-GEOD-2466, E-GEOD-7307

Stimulation
studied in E-GEOD-4883, E-GEOD-23984

stimulus
studied in E-GEOD-22103

Strain or line
studied in E-TABM-125

Subtype
studied in E-GEOD-24283

Survival time
studied in E-GEOD-19188

targeted_cell_type
studied in E-MEXP-70

Test result
studied in E-GEOD-1926, E-TABM-276

Tissue
studied in E-GEOD-30573

Treatment
studied in E-MEXP-973, E-GEOD-19246, E-GEOD-12198

Tumor grading
studied in E-GEOD-4290, E-GEOD-3494, E-GEOD-4922

Vehicle
studied in E-GEOD-5258

Processing time: 0.345 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM